secwatch / observer
8-K filed July 1, 2022, 7:59 PM ET ticker WGS CIK 0001818331
leadership confidence high sentiment neutral materiality 0.35

Sema4 CAO Shawn Assad to resign; Richard Miao appointed Principal Accounting Officer

GeneDx Holdings Corp.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Richard Miao

Principal Accounting Officer
WGS · GeneDx Holdings Corp.
Effective
2022-08-30
Filed
July 1, 2022, 7:59 PM ET
Effective upon Mr. Assad’s departure, Richard Miao will serve as the Company’s Principal Accounting Officer.
Departed

Shawn Assad

Chief Accounting Officer
WGS · GeneDx Holdings Corp.
Effective
2022-08-30
Successor
Richard Miao
Filed
July 1, 2022, 7:59 PM ET
On June 27, 2022, Shawn Assad notified Sema4 Holdings Corp. (the “Company”) that he will resign from his role as Chief Accounting Officer of the Company, effective August 30, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Miao was appointed as Principal Accounting Officer at GeneDx Holdings Corp..

Action
will serve
Role
Principal Accounting Officer
Exact text from the filing
Effective upon Mr. Assad’s departure, Richard Miao will serve as the Company’s Principal Accounting Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Shawn Assad resigned as Chief Accounting Officer at GeneDx Holdings Corp..

Action
resigned
Role
Chief Accounting Officer
Exact text from the filing
On June 27, 2022, Shawn Assad notified Sema4 Holdings Corp. (the “Company”) that he will resign from his role as Chief Accounting Officer of the Company, effective August 30, 2022.
View on SEC.gov

GeneDx Holdings Corp. filing history →

Source: SEC EDGAR
accession 0001818331-22-000060
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.